Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medivation Reports First Quarter 2011 Financial Results and Provides Corporate Update
Yahoo/MarketWire
Saturday, May 7, 2011 - 10:07am
tags:
Medivation, MDV3100, prostate cancer, earnings
Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No
Seeking Alpha
Saturday, May 7, 2011 - 9:40am
tags:
Cytori
Molecular Insight Announces Confirmation of Plan of Reorganization
Yahoo/MarketWire
Saturday, May 7, 2011 - 9:38am
tags:
Molecular Insight
ONYX Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Saturday, May 7, 2011 - 9:34am
tags:
ONYX Pharmaceuticals
Report: GSK has no plans to sell HIV unit
Fierce Biotech
Friday, May 6, 2011 - 10:04am
tags:
HIV, M&A, GSK, ViiV Healthcare, Pfizer
Medicare Overhaul Unlikely to Be Part of Budget Talks
WSJ Online
Friday, May 6, 2011 - 10:01am
tags:
Medicare, healthcare reform
Isis Pharmaceuticals' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Friday, May 6, 2011 - 9:12am
tags:
Isis Pharmaceuticals, earnings
Warner Chilcott 1Q loss widens on tax costs
Yahoo/AP
Friday, May 6, 2011 - 9:11am
tags:
Warner Chilcott, earnings
Dusa Pharma says skin treatment sales continued to rise in 1st quarter; stock jumps
Yahoo/AP
Friday, May 6, 2011 - 8:57am
tags:
DUSA pharmaceuticals, earnings, Levulan photodynamic therapy
J&J, Generics Makers to Revamp Children's Tylenol Products
Motley Fool
Friday, May 6, 2011 - 8:56am
tags:
JNJ, generics, Tylenol, acetaminophen
Advanced Life Sciences Suspends Operations
Yahoo
Friday, May 6, 2011 - 8:41am
tags:
Advanced Life Sciences
Sequenom Beats Expectations and Completes Clinical Study
Barron's
Friday, May 6, 2011 - 8:38am
tags:
Sequenom, earnings, Downs Syndrome
Celgene Stock Falls On Worries About Secondary Cancers
Forbes
Friday, May 6, 2011 - 8:37am
tags:
Celgene, cancer, Multiple Myeloma, Revlimid
Novartis’s Afinitor Wins FDA Approval for Jobs’s Cancer Type
Bloomberg
Friday, May 6, 2011 - 8:06am
tags:
Novartis, Afinitor, FDA, pancreatic cancer
Pfizer’s Decade At A Glance
Forbes
Friday, May 6, 2011 - 8:05am
tags:
Pfizer
Sanofi-Aventis opts out of Metabolex diabetes drug deal
Bizjournals.com
Friday, May 6, 2011 - 8:01am
tags:
Metabolex, diabetes, Sanofi
Targacept profit climbs 85 percent
Bizjournals.com
Friday, May 6, 2011 - 7:47am
tags:
Targacept, earnings
Higher-than-Expected Loss at Onyx
Yahoo/Zacks.com
Thursday, May 5, 2011 - 1:58pm
tags:
ONYX Pharmaceuticals, earnings
Vanda 1Q profit falls 74 percent on revenue drop
Yahoo/AP
Thursday, May 5, 2011 - 1:57pm
tags:
earnings, Vanda
Merck, Teva Near Settlement Over Vytorin Copy, Records Show
Bloomberg
Thursday, May 5, 2011 - 1:56pm
tags:
Merck, Teva Pharmaceuticals, Vytorin, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.